Leonardus H. T. van der Ploeg
Chairman chez Riffit, Inc.
Profil
Leonardus H.
T.
van der Ploeg is currently the Chairman & Chief Scientific Officer at Riffit, Inc. and the Managing Director at VDP LLC.
He was previously the Chief Scientific Officer at Allergan GI Corp.
and the Head-Research & Development at Abraxis Health, Inc. He has also held positions as Director at Retrotope, Inc. and Neurotez, Inc., SVP-Integrative Medicine & Translational Science at Abraxis BioScience, Inc., Chief Scientific Officer at Rhythm Pharmaceuticals, Inc., and Vice President-Basic Research at Merck Research Laboratories Massachusetts LLC.
Prior to his industry experience, he was an Associate Professor at The Trustees of Columbia University in The City of New York.
He received his graduate degree from the University of Amsterdam in 1980.
Postes actifs de Leonardus H. T. van der Ploeg
| Sociétés | Poste | Début |
|---|---|---|
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Chief Tech/Sci/R&D Officer | 30/11/2011 |
VDP LLC
 VDP LLC Other Consumer SpecialtiesConsumer Durables VDP LLC is a private company that manufactures and sells jewelry through online. The company is based in Rochester, MI. | Corporate Officer/Principal | - |
Excellentia Global Partners
 Excellentia Global Partners Financial ConglomeratesFinance Excellentia Global Partners is a life sciences investment bank that works with life science companies, medical device, diagnostic/proteomics companies. The private company is based in New York, NY. The company connects its life science clients with sources of capital in the venture capital and private equity arena. The CEO of the company is Keith M. Gottesdiener. | Corporate Officer/Principal | - |
Riffit, Inc.
 Riffit, Inc. Medical/Nursing ServicesHealth Services Riffit, Inc. is a generative AI company that enables anyone to convert text into a personalized song in real-time. The company is based in Plymouth, MA, and the CEO of the company is Deepak Savadatti. The company's innovative platform offers two products, Songr and Riffit Reader, that help individuals and organizations reach their full potential. Riffit's text-to-song technology allows anyone to create a song in just a few clicks, without any prior musical experience. | Chairman | - |
Anciens postes connus de Leonardus H. T. van der Ploeg
| Sociétés | Poste | Fin |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2019 |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
Neurotez, Inc.
 Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Director/Board Member | - |
Retrotope, Inc.
 Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Director/Board Member | - |
Formation de Leonardus H. T. van der Ploeg
| University of Amsterdam | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Abraxis Health, Inc.
 Abraxis Health, Inc. BiotechnologyHealth Technology Abraxis Health is establishing as a fully-integrated, next-generation, evidence-based, and personalized healthcare company. It plans to develop a proprietary model for the delivery of healthcare. Abraxis Health is designing and acquiring the necessary infrastructure and plans to acquire and internally develop the hardware and software modules to organize and integrate the data streams that form the foundation of an interactive database. The firm will develop, test, and validate diagnostics and drugs to target pre-selected patients based on molecular profiles that predict drug response to particular therapeutics. | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
Retrotope, Inc.
Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Health Technology |
VDP LLC
VDP LLC Other Consumer SpecialtiesConsumer Durables VDP LLC is a private company that manufactures and sells jewelry through online. The company is based in Rochester, MI. | Consumer Durables |
Neurotez, Inc.
Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Health Technology |
Excellentia Global Partners
Excellentia Global Partners Financial ConglomeratesFinance Excellentia Global Partners is a life sciences investment bank that works with life science companies, medical device, diagnostic/proteomics companies. The private company is based in New York, NY. The company connects its life science clients with sources of capital in the venture capital and private equity arena. The CEO of the company is Keith M. Gottesdiener. | Finance |
Riffit, Inc.
Riffit, Inc. Medical/Nursing ServicesHealth Services Riffit, Inc. is a generative AI company that enables anyone to convert text into a personalized song in real-time. The company is based in Plymouth, MA, and the CEO of the company is Deepak Savadatti. The company's innovative platform offers two products, Songr and Riffit Reader, that help individuals and organizations reach their full potential. Riffit's text-to-song technology allows anyone to create a song in just a few clicks, without any prior musical experience. | Health Services |
